BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 7888528)

  • 1. Pott's disease caused by Mycobacterium xenopi: case report and review.
    Miller WC; Perkins MD; Richardson WJ; Sexton DJ
    Clin Infect Dis; 1994 Dec; 19(6):1024-8. PubMed ID: 7888528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol.
    Research Committee of the British Thoracic Society
    Thorax; 2001 Mar; 56(3):167-72. PubMed ID: 11182006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pulmonary mycobacteriosis due to Mycobacterium xenopi" in-vitro sensitivity to classical antitubercular agents and clinical development].
    Baugnée PE; Pouthier F; Delaunois L
    Acta Clin Belg; 1996; 51(1):19-27. PubMed ID: 8669159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relapsing Pott disease caused by Mycobacterium heckeshornense in a well-controlled HIV-infected patient.
    Douiri N; Lefebvre N; Hansmann Y; Partisani M; Schramm F
    Med Mal Infect; 2018 Mar; 48(2):157-158. PubMed ID: 29373165
    [No Abstract]   [Full Text] [Related]  

  • 5. Mycobacterium xenopi, Mycobacterium fortuitum, Mycobacterium kansasii, and other nontuberculous mycobacteria in an area of endemicity for AIDS.
    Shafer RW; Sierra MF
    Clin Infect Dis; 1992 Jul; 15(1):161-2. PubMed ID: 1617056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of Mycobacterium xenopi in human disease.
    Simor AE; Salit IE; Vellend H
    Am Rev Respir Dis; 1984 Mar; 129(3):435-8. PubMed ID: 6703502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnosis and treatment of atypical mycobacterial infections of the respiratory tract].
    Andréjak C; Lescure FX; Schmit JL; Jounieaux V
    Rev Mal Respir; 2011 Dec; 28(10):1293-309. PubMed ID: 22152937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculous spondylitis (Pott's disease).
    Nigg AP; Schulze-Koops H; Wirth S; Weiss M; Bogner JR
    Infection; 2008 Jun; 36(3):293-4. PubMed ID: 18473118
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug susceptibility testing of slowly growing non-tuberculous mycobacteria using slomyco test-system.
    Litvinov V; Makarova M; Galkina K; Khachaturiants E; Krasnova M; Guntupova L; Safonova S
    PLoS One; 2018; 13(9):e0203108. PubMed ID: 30222736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical Pott's disease: localized infection of the thoracic spine due to Mycobacterium avium-intracellulare in a patient without human immunodeficiency virus infection.
    Mehta JB; Emery MW; Girish M; Byrd RP; Roy TM
    South Med J; 2003 Jul; 96(7):685-8. PubMed ID: 12940321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Parotitis due to Mycobacterium and HIV infection].
    Benharrats I; Jacob L; Taulera O
    Rev Med Interne; 1998 Sep; 19(9):676-7. PubMed ID: 9793160
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful treatment of pulmonary Mycobacterium xenopi infection in a natural killer cell-deficient patient with clarithromycin, rifabutin, and sparfloxacin.
    Schmitt H; Schnitzler N; Riehl J; Adam G; Sieberth HG; Haase G
    Clin Infect Dis; 1999 Jul; 29(1):120-4. PubMed ID: 10433574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Osteoarticular Mycobacterium xenopi infection].
    Ollagnier E; Frésard A; Guglielminotti C; Carricajo A; Mosnier JF; Alexandre C; Lucht F
    Presse Med; 1998 May 2-9; 27(17):800-3. PubMed ID: 9767883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pott's disease caused by Mycobacterium xenopi.
    Jones PG; Schrager MA; Zabransky RJ
    Clin Infect Dis; 1995 Nov; 21(5):1352. PubMed ID: 8589186
    [No Abstract]   [Full Text] [Related]  

  • 15. Pulmonary infection with nontuberculous mycobacteria.
    Contreras MA; Cheung OT; Sanders DE; Goldstein RS
    Am Rev Respir Dis; 1988 Jan; 137(1):149-52. PubMed ID: 3337456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Other Nontuberculous Mycobacteria.
    Basille D; Jounieaux V; Andréjak C
    Semin Respir Crit Care Med; 2018 Jun; 39(3):377-382. PubMed ID: 30071552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycobacterial Musculoskeletal Infections.
    Hogan JI; Hurtado RM; Nelson SB
    Infect Dis Clin North Am; 2017 Jun; 31(2):369-382. PubMed ID: 28292541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical mycobacterial vertebral osteomyelitis: case report and review.
    Sarria JC; Chutkan NB; Figueroa JE; Hull A
    Clin Infect Dis; 1998 Feb; 26(2):503-5. PubMed ID: 9502484
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of characteristics of patients and treatment outcome for pulmonary non-tuberculous mycobacterial infection and pulmonary tuberculosis.
    Al Jarad N; Demertzis P; Jones DJ; Barnes NC; Rudd RM; Gaya H; Wedzicha JA; Hughes DT; Empey DW
    Thorax; 1996 Feb; 51(2):137-9. PubMed ID: 8711643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infection by Mycobacterium szulgai in a patient with pulmonary tuberculosis.
    Olmos JM; Peralta FG; Mellado A; González-Macías J
    Eur J Clin Microbiol Infect Dis; 1994 Aug; 13(8):689-90. PubMed ID: 7813507
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.